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In the animal model of the Syrian hamster the antian-
drogenic action of spironolactone on the sebaceous 
glands of the ventral side of the pinna was examined. 
Spironolactone reduces both labeling index and cross-
sectional surface area of sebaceous glands significantly 
in a dose-dependent manner. Equally there was a sig-
nificant decrease in serum testosterone levels in spirono-
lactone treated animals. Our results seem to justify clin-
ical studies with spironolactone in patients with hirsu-
tism., serborrhea, and possibly acne vulgaris. 
The synthetic mineralosteroid spironolactone (SL) is rou-
tinely used as an aldosterone antagonist [1]. SL actively com-
petes for aldosterone receptors at the distal tubule and inhibits 
active sodium reabsorption. It is used as a diuretic and antihy-
pertensive medication. 
A long-lasting therapy with SL is frequently associated with 
estrogenic side effects such as gynecomastia, impotence, and 
decreased libido [2,3]. These effects might be partly due to the 
inhibition of testosterone biosynthesis; however, the pathome-
chanisms of these side reactions are not yet clear [ 4,5]. As 
shown in animal experiments, the cytochrome P-450 in the. 
microsomal testis fraction is destroyed, and consecutively, the 
activity of the 17 -a-hydroxylase is decreased, which is necessary 
for the formation of testosterone from pregnenolone and pro-
gesterone [6). Contradictory findings have been published from 
human volunteers, where a concomitant increase of progester-
one and 17-a-hydroxyprogesterone in plasma was observed 
after systemic application of SL [7]; it should be noted that the 
SL dose used in humans was considerably lower than in the 
above mentioned animal experiments. 
Patients, who take 200-400 mg SL daily show a more rapid 
metabolic clearance of testosterone [3]. FUl'thermore the con-
version of testosterone to estradiol is increased in these individ-
uals leading to elevated serum estradiol [3). On this basis one 
could postulate changes in the common sex-hormone binding 
globulin (SHBG) in this manner, that increased estrogen results 
in an increased SHBG concentration, which limits the activity 
of androgens [8]. 
SL also has a specific antiandrogenic effect at the level of the 
peripheral androgen cytosol receptors and reduces the nuclear 
concentrations of testosterone- and dihydrotestosterone-recep-
tor complexes, as shown in animal experiments examining the 
androgen receptor in the skin [9] and the prostate [10,11). SL 
taken in doses such as used in the therapy of hirsute women 
decreases the number of available androgen binding sites [9]. 
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The effect of SL on the sebaceous gland size and sebocyte 
proliferation has not been investigated. Using the animal model 
of the Syrian hamster ear [12-14] we investigated the effect of 
SL on sebaceous glands. 
ANIMAL MODEL 
The effects of hormones and hormonal active substances on seba-
ceous glands can be tested on the animal model of the Syrian hamster 
ear [12-14). On the ventral sites of the pinna of the Syrian hamster 
there are many androgen dependent sebaceous glands. The hamster 
sebaceous glands fo1·m pilo-seboglandular units and are comparable to 
human sebaceous follicles (12-14). The size of sebaceous glands and 
the sebocyte proliferation of Syrian hamster reflect th~ activity of 
sebaceous glands, and therefore, the sebum production. This conelates 
with the serum testosterone level [14). 
In hamsters testosterone shows a daily rhythm with higher valu es 
dw·ing daytime than at night and in the early morning [15). ln addition, 
Syrian hamsters have a mru·ked annual cycle in reproduct ion activity, 
which is dependent from photoperiods. Long photoperiods in summer 
(14h daylight) lead to sexual activity with high testosterone levels. In 
autumn and winter, the reproductive activity is reduced, the serum 
testosterone concentration is diminished, and the sebaceous gland 
activity is minimized (unpublished data) . Thus animal studies should 
be performed during summer months or under constant 14h light 
exposure imitating summer day]jght periods (16]. 
MATERIALS AND METHODS 
Animals 
Experiments were done in mature long-day adapted (14h daylight) 
male animals (90-110 gm), kept indoors ·in constant temperature and 
maintained on a standru·d diet. 
Treatment 
Treatment was performed over a period of 24 days (6/ 7 days). The 
animals were divided into groups I and II. The animals of group I (N 
= 8) 0.5 mg SL (6 mg/ kg BW) and the animals of group II (N = 8) 2.0 
mg SL (25 mg/ kg BW) were injected subcutaneously. 
SL was dissolved in ricinus oil:benzyl benzoate 6:4. 
Controls 
These included vehicle treated (N 
adapted male animals (N = 8). 
Biopsies 
5) and untreated long-day 
All animals were biopsied 4 days after the last SL injection and at 
the same time between 3:00 and 4:00 PM. Specimens were ftxed in 
formalin and wax-embedded. Sagittal sections were cut at 5fL thickness, 
tangential cuts were omitted. 
Testosterone Determination 
Blood was collected into heparinized tubes and the plasma was 
separated by centrifugation and kept frozen at -20°C until assayed for 
testosterone. Plasma concentrations of testosterone were deteimined 
by radioimmunofogicaf methods similru· to those described for estrogens 
[17]. In brief, plasma samples to which radioactive traceramounts of 
the respective steroids have been added, were extracted with ethel'. 
The dl'ied extracts were chromatographed on Sephadex LH-20 columns 
(gel bed 140 X 7 mm) with benzene/ ethanol (95:5) as the solvent. The 
fractions were collected sepru·ately. 
Final quantification of the steroids was achieved by radioimmuno-
logical methods using highly specific antisera which were ra ised by 
injecting rabbits with testosterone-3-BSA (BSA:bovine serum albu-
min). The sensitivity of this method was 3 ng/ dl and the in terassay 
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variabiUty was 6.8% for testosterone. There was no in terference of SL 
wi th the testosterone assay. 
Measurements 
Planimetric evaluation of cross-sectional surface areas were done 
with a standardized technique [12-14). In short, t his involved projection 
microscopy with a daylight projecting mirror (Zeiss), using a microscope 
with a x25 lens to give a final linear magnification of 420. The micro-
scope was attached to a MOP-area counter (Kontron, Munich). 30-50 
sections were made from each biopsy, more than 50 sebaceous fo llicles 
were evaluated and the results were expressed in mm''-
Autoradiography 
Tritiated thymidine CH-TdR), specific actwtty 5Ci/mM (Radio-
chemical Centre, Amersham, England) was used to determine the 
labeling index (LI) . Ten microcuries in no•·mal saline were injected with 
a 27-gauge needle into the ventral side of each pinna. The animals were 
sacrificed 45 min later. The dipping method was used as described 
previously (18,19]. LI was determined fro m the ratio of labeled sebo-
cytes to t he total number of germinative sebocytes in per cent. 
Statistics 
For statistical analysis the independent Student's t-test was used. 
RESULTS 
Controls 
There we1·e no significant differences between the average 
follicle area and the LI in the vehicle treated and untreated 
animals (Fig 1) . Microscopically, the acini were filled with 
sebocytes migrating from the periphery into the duct, t he 
cytoplasm of the sebocytes increasing in size and the nucleus 
diminishing. The infundibula were elongated without retention 
of corneocytes. The results are summarized in the Table. 
c 
... ""' 
Ftc 1. Large sebaceous glands in untreated male Syrian hamsters. 
Many ' H-TdR labeled sebocytes (i) and keratinocytes (i). C =cartilage 
(reduced from X 220). 
Summary of experimental data using spironolactone in Syrian 
hamsters 
Dose 
2.0 mg SL 
N ""8 










(mm2 X 10- '' ) 
and SO 
600 ± 335" 
740 ± 360'' 
1230 ± 270" 
SD: Standard deviation. 
Labeling index Serum testosterone 
in % and SO (ng/ dl) and SO 
6.5 ± 4" 48.2 ± 21" 
12.4 ± (i" 141.6 ± 70" 
18.4 ± 7" 359 ± 147" 
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FIG 2. Reduction of sebaceous follicles with in tralobular cavity ( •) 
in Syrian hamsters treated with 0.5 mg spironolactone da ily. Few 
labeled sebocytes (t) (reduced from x 220) . 
FrG 3. Pronounced reduction of sebaceous follicles with cyst-like 
cavity ( • ) in Syrian hamsters treated with 2.0 mg spironolactone daily. 
Few labeled sebocytes (j) (reduced from X 220). 
Spironolactone 
The SL-treated male animals differ from the controls in all 
parameters assessed (Table). The pelage of the animal in group 
I and group II became dry and lost their silky appearance 
compared to the pelage of t he control animals. The follicle show 
few seboc:ytes and cyst-like infundibula without retention of 
co.rneocytes (Fig 2,3) . The cross-sectional sw·face areas of se-
baceous glands were reduced by 40% in group I and 53% in 
group II. The labeling index is decreased to 67% in group I and 
35% in group II. Furth ermore, the testosterone level is reduced 
significantly in group I by 60% and in group II by 87%. 
DISCUSSION 
The activity of the sebaceous glands is under control of 
testosterone (20,21]. The sebaceous glands are small in child· I 
hood. At the start of the puberty there is an increase of 
testosterone and skin surface lipids; acne vulgaris occurs if a 
predisposition is present. As an expression of the elevated 
sebaceous gland activity the sebaceous follicles are large and 
the '1H-TdR- labeling index of the germinal cells situated on the 
basal membrane of the sebaceous glands is increased [18]. 
The mode of action of testosterone on sebocyte proliferation 
and lipogenesis is not yet clear. In a variety of target organs 
(also in the siUn) testosterone is converted to dihydrotestoster-
one by the 5o:-reductase [22-24], which is found in a high degTee 
in sebaceous glands [25). The intracellula1· action of steroid 
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hormones are characterized by an unitarian mode of action 
[26]. The cytoplasm of the androgenresponse cells is thought to 
be the reservoir of an androgenbinding receptor. Wide accept-
ance has been given that the hormone receptor complex formed 
in the cytoplasm migrates into the nucleus, where it exertes 
various influence on the properties of DNA including its tran-
scription by RNA polymerase [27,28]. 
Testosterone action on sebaceous glands activity can be 
influenced by SL on various levels [2- 7]. In the sensitive model 
of the Syrian hamster ear it reduces significantly the serum 
level of the main androgen testosterone. The elevated periph-
eral metabolic clearance and the increased conversion of tes-
tosterone to estradiol [3], which is sebosuppressive itself by a 
central inhibition of gonadotropinreleasing hormone secretion 
and a reduction of Sa-reductase activity [24], might lead to a 
further inhibition of sebocyte proliferation. Finally, cytoplasmic 
androgen receptors are blocked by SL [9-11], which causes a 
decrease of free androgen binding sites [9]. It is not certain 
which of the various effects predominate but it is likely that 
the competitive inhibition with dihydrotestosterone for recep-
tor sites is important. · 
In our animal experiments the activity of sebaceous glands 
was reduced significantly by SL. There was a dose-dependent 
decrease of the LI, that is a direct measure of sebocyte prolif-
eration. Correspondingly, the sebocyte population was dimin-
ished, as documented by the intralobular cyst-like cavity (Fig 
2,3). 
Furthermore, the cross-sectional suTface areas of sebaceous 
glands of the Syrian hamster shrank. Probably, the reduction 
of the follicle areas is a secondary effect caused by the inhibition 
of sebocytes mitoses and endogenous lipid production within 
the sebocytes. 
Our results seem to justify clinical studies with SL in patients 
with hisutism, seborrhea, and probably acne vulgaris. 
The technical assistence of Miss. A. Ruhfus is kindly acknowledge-
ment. 
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